Yttrium 90 ibritumomab tiuxetan radioimmunotherapy for relapsed or refractory low-grade non-hodgkin's lymphoma

Leo I. Gordon*, Thomas E. Witzig, Greg A. Wiseman, Ian W. Flinn, Stewart S. Spies, Daniel H. Silverman, Christos Emmanuolides, Larry Cripe, Mansoor Saleh, Myron S. Czuczman, Teresa Olejnik, Christine A. White, Antonio J. Grillo-López

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

65 Scopus citations

Fingerprint

Dive into the research topics of 'Yttrium 90 ibritumomab tiuxetan radioimmunotherapy for relapsed or refractory low-grade non-hodgkin's lymphoma'. Together they form a unique fingerprint.

Medicine & Life Sciences